Scientists developing new therapy for HER2-positive breast cancer
Tuesday, July 26, 2011 - 16:30
in Health & Medicine
Patients with HER2-positive breast cancer may have an alternative therapy when they develop resistance to trastuzumab, also known as Herceptin, according to a new laboratory finding.